4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-23-105924
Chief Executive Officer bought 98,000 shares at $0.51 ($49,980)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudley Robert Michael Chief Executive Officer | 2023-09-28 | Purchase | +98,000 | $0.51 | $49,980 | 180,262 | D |
| Open-market purchases · 98,000 sh · avg $0.51 · $49,980 | |||||||
Loading xslF345X05/tm2327413-1_4seq1.xml…